SA PRO
Free Account
Themes
Regeneron Pharmaceuticals, Inc.REGNNASDAQ
Loading
OverviewIntelligenceChartsNews

Analyst Sentiment

Analysts lean bullish — 83% recommend buying.

Consensus Rating
Buy
23 analysts·High coverage
83%
Rating Distribution
Strong Buy
00%
Buy
1983%
Hold
417%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see modest upside — consensus target 12% higher.

Bear Case
$700.00
-9%
Consensus
$858.28
+12%
Bull Case
$1057.00
+38%
Price Range23 analysts
Low
Consensus
High
$700.00
$1057.00
Current Target
Current Price
$766.66
Upside to Target
$91.62

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Mar 2, 2026RBC Capital
Regeneron Pharma (REGN) PT Raised to $765 at RBC Capital
Target:$765.00
-2.4%from $784.06
Feb 9, 2026Guggenheim
Regeneron price target raised to $975 from $865 at Guggenheim
Target:$975.00
+24.1%from $785.51
Feb 2, 2026Cantor Fitzgerald
Regeneron price target raised to $800 from $740 at Cantor Fitzgerald
Target:$800.00
+5.6%from $757.59
Feb 2, 2026Robert W. Baird
Regeneron price target raised to $742 from $630 at Baird
Target:$742.00
-1.8%from $755.34
Feb 2, 2026Oppenheimer
Regeneron price target raised to $865 from $750 at Oppenheimer
Target:$865.00
+16.7%from $741.45
Feb 2, 2026Tudor Pickering
Regeneron Pharma (REGN) PT Raised to $925 at Bernstein SocGen Group
Target:$925.00
+22.8%from $753.13
Feb 1, 2026Morgan Stanley
Regeneron price target raised to $769 from $768 at Morgan Stanley
Target:$769.00
+3.7%from $741.45
Jan 30, 2026Raymond James
Regeneron price target raised to $870 from $820 at Raymond James
Target:$870.00
+17.3%from $741.45
Jan 27, 2026Tudor Pickering
Regeneron Pharma (REGN) PT Raised to $916 at Bernstein
Target:$916.00
+20.2%from $762.10
Jan 27, 2026RBC Capital
RBC Capital Reiterates Sector Perform Rating on Regeneron Pharma (REGN)
Target:$745.00
-3.1%from $769.05
Jan 27, 2026Bernstein
Regeneron price target raised to $916 from $911 at Bernstein
Target:$916.00
+20.1%from $762.65
Jan 22, 2026Evercore ISI
Regeneron price target raised to $875 from $750 at Evercore ISI
Target:$875.00
+14.9%from $761.56
Jan 8, 2026Goldman Sachs
Regeneron price target raised to $914 from $807 at Goldman Sachs
Target:$914.00
+12.5%from $812.27
Dec 17, 2025Leerink Partners
Regeneron Pharma (REGN) PT Raised to $873 at Leerink Partners
Target:$873.00
+17.0%from $746.36
Dec 12, 2025Morgan Stanley
Regeneron price target raised to $768 from $767 at Morgan Stanley
Target:$768.00
+3.6%from $741.51
Dec 10, 2025HSBC
Regeneron price target raised to $985 from $890 at HSBC
Target:$985.00
+42.2%from $692.58
Dec 4, 2025BMO Capital
Regeneron price target raised to $850 from $725 at BMO Capital
Target:$850.00
+17.5%from $723.67
Dec 4, 2025Canaccord Genuity
Regeneron price target raised to $1,057 from $850 at Canaccord
Target:$1057.00
+46.1%from $723.67
Nov 24, 2025Truist Financial
Regeneron assumed with a Buy at Truist
Target:$798.00
+4.1%from $766.50
Nov 24, 2025Scotiabank
Regeneron price target raised to $770 from $650 at Scotiabank
Target:$770.00
+0.1%from $769.23
Nov 24, 2025HSBC
Regeneron initiated with a Buy at HSBC
Target:$890.00
+17.7%from $755.90
Nov 20, 2025Wells Fargo
Regeneron price target raised to $700 from $615 at Wells Fargo
Target:$700.00
-0.4%from $702.75
Oct 29, 2025RBC Capital
Regeneron price target raised to $708 from $704 at RBC Capital
Target:$708.00
+8.4%from $653.01
Oct 29, 2025Cantor Fitzgerald
Regeneron Pharma (REGN) PT Raised to $740 at Cantor Fitzgerald
Target:$740.00
+12.6%from $657.00
Oct 29, 2025BMO Capital
Regeneron price target raised to $725 from $640 at BMO Capital
Target:$725.00
+10.8%from $654.48

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance